28/04/2017 IARC and the Pan American Health Organization (PAHO) jointly hosted a meeting in Washington, DC, USA, on 24 and 25 April with representatives from cancer and public health institutions in Latin America and the Caribbean to explore the possibility of developing an evidence-based set of cancer prevention messages targeted to the general population of the region. Read more, View photo
An international study coordinated by the International Agency for Research on Cancer (IARC) and published today in The Lancet Oncology shows that in 20012010, childhood cancer was 13% more common than in the 1980s, reaching an annual incidence rate of 140 per million children aged 014 years worldwide.
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, Hesseling P, Shin HY, Stiller CA, and the IICC-3 contributors.
International incidence of childhood cancer, 200110: a population-based registry study. Lancet Oncol. Published online 11 April 2017.
Read article, IARC Press Release 251
A Working Group of 17 scientists from 10 countries met at the International Agency for Research on Cancer (IARC) on 2128 March 2017 to evaluate the carcinogenicity of welding, molybdenum trioxide, and indium tin oxide. A summary of the evaluations has now been published in The Lancet Oncology. The detailed assessments will be published as Volume 118 of the IARC Monographs.
Guha N, Loomis D, Guyton KZ, Grosse Y, El Ghissassi F, Bouvard V, et al.
Carcinogenicity of welding, molybdenum trioxide, and indium tin oxide
Lancet Oncol, Published online 10 April 2017;
12/04/2017 Read more
WHO/IARC Classification of Tumours, 4th Edition, Volume 9: WHO Classification of Head and Neck Tumours
The WHO Classification of Head and Neck Tumours is the ninth volume in the 4th Edition of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies evaluating response to therapy and clinical outcome.
Diagnostic criteria, pathological features, and associated genetic alterations are described in a disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, epidemiology, clinical features, macroscopy, pathology, genetics, and prognosis and predictive factors.